Main competitors
Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
60.05B
AAA
8.1B
BBB
8.02B
AA
5.4B
AAA
4.85B
AA
2.83B -
BB
- -
2.71B - -
2.4B - - - - - -
1.96B - - - - -
1.92B - - - - - -
1.85B -
BBB
- - - - -
1.64B - - - - - - -
1.6B - - - - - - -
1.36B
CCC
-
1.22B - - - - - -
1.21B
BBB
1.19B - - - -
1.1B - - - - -
1.03B - - - - - - -
993M
BBB
Average 5.57B
A
Weighted average by Cap.
A
Specialty & Advanced Pharmaceuticals